Cargando…
Rapid systematic review of smoking cessation interventions for people who smoke and have cancer
BACKGROUND: Higher rates of cancer are reported in smokers compared to non-smokers, and continued smoking following a cancer diagnosis is associated with reduced health outcomes and survival. Despite international evidence of increased risks, a substantial percentage of people with a cancer diagnosi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834964/ http://dx.doi.org/10.1093/eurpub/ckac129.556 |
_version_ | 1784868578019770368 |
---|---|
author | Frazer, K Bhardwaj, N Fox, P Niranjan, V Quinn, S Kelleher, C Fitzpatrick, P |
author_facet | Frazer, K Bhardwaj, N Fox, P Niranjan, V Quinn, S Kelleher, C Fitzpatrick, P |
author_sort | Frazer, K |
collection | PubMed |
description | BACKGROUND: Higher rates of cancer are reported in smokers compared to non-smokers, and continued smoking following a cancer diagnosis is associated with reduced health outcomes and survival. Despite international evidence of increased risks, a substantial percentage of people with a cancer diagnosis continue to smoke. Patients may be unaware of the additional risks associated with continued smoking, and health care professionals may not engage with quit supports. As part of a larger feasibility study to develop a smoking cessation pathway in cancer services in Ireland, a rapid review of the evidence was completed. METHODS: Systematic searches of PubMed, Embase, and CINAHL 2015 to December 2020 were conducted; with studies restricted to adults with a cancer diagnosis [lung, breast, cervical, head and neck] and published in English. No restriction was placed on study designs. 6404 studies were identified and uploaded into COVIDENCE platform, Cochrane's systematic review methods were adopted throughout, PRISMA reporting guidelines were used, and narrative data synthesis was completed (CRD 42020214204). RESULTS: The twenty-three-studies report evidence from USA, Canada, England, Lebanon, and Australia. The setting for all interventions was hospitals and cancer clinics. Evidence identifies high dropout rates, inconsistencies in approaches and duration of smoking cessation interventions with varied outcomes. A wide-ranging number of critical components emerged associated with optimal quit support- including the timing of and frequency of quit conversations, use of electronic records, in-person support meetings, provision of nicotine replacement therapy and extended use of Varenicline, smoking cessation services embedded in oncology depts, and engaging with families wanting to quit at the same time. CONCLUSIONS: Developing tailored smoking cessation interventions are needed for smokers diagnosed with cancer to enable engagement. KEY MESSAGES: • Continued smoking following a cancer diagnosis is associated with reduced health outcomes. • Smoking cessation programmes for cancer patient should be tailored to meet needs. |
format | Online Article Text |
id | pubmed-9834964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-98349642023-01-12 Rapid systematic review of smoking cessation interventions for people who smoke and have cancer Frazer, K Bhardwaj, N Fox, P Niranjan, V Quinn, S Kelleher, C Fitzpatrick, P Eur J Public Health Parallel Programme BACKGROUND: Higher rates of cancer are reported in smokers compared to non-smokers, and continued smoking following a cancer diagnosis is associated with reduced health outcomes and survival. Despite international evidence of increased risks, a substantial percentage of people with a cancer diagnosis continue to smoke. Patients may be unaware of the additional risks associated with continued smoking, and health care professionals may not engage with quit supports. As part of a larger feasibility study to develop a smoking cessation pathway in cancer services in Ireland, a rapid review of the evidence was completed. METHODS: Systematic searches of PubMed, Embase, and CINAHL 2015 to December 2020 were conducted; with studies restricted to adults with a cancer diagnosis [lung, breast, cervical, head and neck] and published in English. No restriction was placed on study designs. 6404 studies were identified and uploaded into COVIDENCE platform, Cochrane's systematic review methods were adopted throughout, PRISMA reporting guidelines were used, and narrative data synthesis was completed (CRD 42020214204). RESULTS: The twenty-three-studies report evidence from USA, Canada, England, Lebanon, and Australia. The setting for all interventions was hospitals and cancer clinics. Evidence identifies high dropout rates, inconsistencies in approaches and duration of smoking cessation interventions with varied outcomes. A wide-ranging number of critical components emerged associated with optimal quit support- including the timing of and frequency of quit conversations, use of electronic records, in-person support meetings, provision of nicotine replacement therapy and extended use of Varenicline, smoking cessation services embedded in oncology depts, and engaging with families wanting to quit at the same time. CONCLUSIONS: Developing tailored smoking cessation interventions are needed for smokers diagnosed with cancer to enable engagement. KEY MESSAGES: • Continued smoking following a cancer diagnosis is associated with reduced health outcomes. • Smoking cessation programmes for cancer patient should be tailored to meet needs. Oxford University Press 2022-10-25 /pmc/articles/PMC9834964/ http://dx.doi.org/10.1093/eurpub/ckac129.556 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Parallel Programme Frazer, K Bhardwaj, N Fox, P Niranjan, V Quinn, S Kelleher, C Fitzpatrick, P Rapid systematic review of smoking cessation interventions for people who smoke and have cancer |
title | Rapid systematic review of smoking cessation interventions for people who smoke and have cancer |
title_full | Rapid systematic review of smoking cessation interventions for people who smoke and have cancer |
title_fullStr | Rapid systematic review of smoking cessation interventions for people who smoke and have cancer |
title_full_unstemmed | Rapid systematic review of smoking cessation interventions for people who smoke and have cancer |
title_short | Rapid systematic review of smoking cessation interventions for people who smoke and have cancer |
title_sort | rapid systematic review of smoking cessation interventions for people who smoke and have cancer |
topic | Parallel Programme |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834964/ http://dx.doi.org/10.1093/eurpub/ckac129.556 |
work_keys_str_mv | AT frazerk rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer AT bhardwajn rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer AT foxp rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer AT niranjanv rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer AT quinns rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer AT kelleherc rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer AT fitzpatrickp rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer |